BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 38168755)

  • 21. Excitatory Projections from the Prefrontal Cortex to Nucleus Accumbens Core D1-MSNs and κ Opioid Receptor Modulate Itch-Related Scratching Behaviors.
    Wu XB; Zhu Q; Gao MH; Yan SX; Gu PY; Zhang PF; Xu ML; Gao YJ
    J Neurosci; 2023 Feb; 43(8):1334-1347. PubMed ID: 36653189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the inhibition of fatty acid amide hydrolase ameliorate the endocannabinoid-mediated synaptic dysfunction in a valproic acid-induced rat model of Autism.
    Wu HF; Lu TY; Chu MC; Chen PS; Lee CW; Lin HC
    Neuropharmacology; 2020 Jan; 162():107736. PubMed ID: 31398381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Luteolin in the Qi Bi Anshen decoction improves propionic acid-induced autism-like behavior in rats by inhibiting LRP1/MMP9.
    Zhang M; Yu J; Liu A; Liu QQ; Sun T; Li X; Du Y; Li J; Wang B; Yang Q
    Phytomedicine; 2023 Sep; 118():154965. PubMed ID: 37451152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agmatine rescues autistic behaviors in the valproic acid-induced animal model of autism.
    Kim JW; Seung H; Kim KC; Gonzales ELT; Oh HA; Yang SM; Ko MJ; Han SH; Banerjee S; Shin CY
    Neuropharmacology; 2017 Feb; 113(Pt A):71-81. PubMed ID: 27638451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of Epigenetics and Glial Cells in Drug-Induced Autism Spectrum Disorder.
    Csoka AB; El Kouhen N; Bennani S; Getachew B; Aschner M; Tizabi Y
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lotusine ameliorates propionic acid-induced autism spectrum disorder-like behavior in mice by activating D1 dopamine receptor in medial prefrontal cortex.
    Liu QQ; Mi J; Du YY; Rong Z; Qin Y; Jiang W; Li X; Yu JY; Yang L; Du XY; Yang Q; Guo YY
    Phytother Res; 2024 Feb; 38(2):1089-1103. PubMed ID: 38168755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chronic Activation of the Dopaminergic Neuronal Pathway Improves Behavioral Abnormalities in the Prenatal Valproic Acid Exposure Mouse Model of Autism Spectrum Disorder].
    Hara Y
    Yakugaku Zasshi; 2019; 139(11):1391-1396. PubMed ID: 31685735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valproic Acid and Propionic Acid Modulated Mechanical Pathways Associated with Autism Spectrum Disorder at Prenatal and Neonatal Exposure.
    Sharma AR; Batra G; Saini L; Sharma S; Mishra A; Singla R; Singh A; Singh RS; Jain A; Bansal S; Modi M; Medhi B
    CNS Neurol Disord Drug Targets; 2022; 21(5):399-408. PubMed ID: 34365961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prefrontal circuits guiding social preference: Implications in autism spectrum disorder.
    Fortier AV; Meisner OC; Nair AR; Chang SWC
    Neurosci Biobehav Rev; 2022 Oct; 141():104803. PubMed ID: 35908593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopaminergic Dysregulation in Syndromic Autism Spectrum Disorders: Insights From Genetic Mouse Models.
    Kosillo P; Bateup HS
    Front Neural Circuits; 2021; 15():700968. PubMed ID: 34366796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Social circuits and their dysfunction in autism spectrum disorder.
    Sato M; Nakai N; Fujima S; Choe KY; Takumi T
    Mol Psychiatry; 2023 Aug; 28(8):3194-3206. PubMed ID: 37612363
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.